The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2a, open-label, dose-escalation and safety study of APC-100 in men with advanced prostate cancer.
 
Christos Kyriakopoulos
No Relationships to Disclose
 
Elisabeth I. Heath
Honoraria - Bayer; Dendreon
Research Funding - Agensys (Inst); Dendreon (Inst); Genentech/Roche (Inst); Millennium (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)
 
Jens C. Eickhoff
No Relationships to Disclose
 
Jill Kolesar
No Relationships to Disclose
 
Mulusew Yayehyirad
No Relationships to Disclose
 
Thomas Moll
Employment - Adamis
Leadership - Adamis
Stock and Other Ownership Interests - Adamis
Honoraria - Adamis
Consulting or Advisory Role - Adamis
Speakers' Bureau - Adamis
Research Funding - Adamis (Inst)
Patents, Royalties, Other Intellectual Property - Adamis Pharmaceuticals Corporation
Expert Testimony - Adamis
Travel, Accommodations, Expenses - Adamis
 
Glenn Liu
No Relationships to Disclose